October 21, 2024 – Aliri Bioanalysis, a leading provider of advanced bioanalytical and spatial biomarker solutions for drug developers, is pleased to announce its upcoming participation at the American Association of Pharmaceutical Scientists (AAPS) PharmSci 360 Annual Meeting this week in Salt Lake City, Utah. This year’s event holds special significance as Aliri celebrates the30th anniversary of its Salt Lake City, Utah laboratory (formerly Tandem Labs). 

Visit Aliri at AAPS PharmSci 360 booth #2209 to join the celebration and explore the company’s latest bioanalytical advancements.  Our team of experts will be on display throughout the week as they highlight Aliri’s thought leadership and latest scientific innovations in a featured talk by Corinne Ramos, PhD, on the use of AI for personalized medicine, and in a series of 11 scientific poster presentations.  

Aliri is also excited to host a private networking reception on Tuesday, October 22nd at 5:30pm in celebration of its 30th anniversary, where we will bring together colleagues and industry peers for a fun and memorable occasion.  

“This is an exciting time for Aliri and we are proud to be able to celebrate and showcase our decades of experience at AAPS,” stated Aliri CEO, Kent Payne, PhD. Our focus for the last thirty years has been to provide our customers with accurate, relevant, and timely insights that support the advancement of their development program, and this remains our goal today. We are looking forward to many exciting conversations this week and the real potential that our partnerships have to impact the lives of patients around the world.”  

Below is a list of scientific presentations that Aliri will be showcasing at the conference this week.  Click here to learn more about all our activities at AAPS PharmSci 360 and to schedule a meeting with our team. 

Featured Presentation 

• Monday, October 21 @ 10:30 AM: Bioanalytical Lab Innovations 1 – “Artificial Intelligence and Machine Learning for Personalized Medicine” | Presented by Corinne Ramos   

Scientific Posters 

Monday, October 21 

• 9:30 AM | Development of Quantitative MALDI Mass Spectrometry Imaging Methods for Studying Distribution of Antituberculosis Drugs at Their Site of Action (#M0930-06-32) | Presented by Mathieu Gaudin
• 11:30 AM | A Derivatization-Free LCMS Assay for 4β-Hydroxycholesterol (# M1130-06-33) | Presented by Shane Karnik
• 11:30 AM | Phenyl SPE: A Promising Alternative to More Common Oligonucleotide Extraction (#M1130-06-31) | Presented by Brandon Davies
• 1:30 PM | Development of a Mitra Tip Extraction Assay Coupled with LC-MS/MS for Quantitation of L-Citrulline, L-Arginine, and L-Argininosuccinic Acid:  A Novel Approach for Biomarker Analysis (#M1330-02-10) | Presented by Shawn Burton
• 1:30 PM | Quantifying and Mapping ATP Distribution Within Tissues to Inform Targeted Therapeutic Strategies in Drug Development (# M1330-06-32) | Presented by Mathieu Gaudin
• 2:30 PM | Validated Biomarker Assay for the Analysis of Coproporphyrin I and Coproporphyrin III in Human Plasma (#M1430-06-34) | Presented by Shane Karnik
• 2:30 PM | Integrating Omics Data Through AI: Predicting Novel Therapeutic Targets for Therapy-Resistant Cancer Patients (#M1430-02-12) | Presented by Corinne Ramos 

Tuesday, October 22 

• 10:30 AM | Elucidating the Role of IL-8 in NSCLC: Integrated Analysis Through Imaging Mass Cytometry, Mass Cytometry, and Single-Cell Sequencing (#T1030-02-12) | Presented by Corinne Ramos
  
• 1:30 PM | Spatial Distribution of mRNA-Lipid Nanoparticles in Mouse Whole-Body and Isolated Organs Using MALDI MSI (#T1330-01-05) | Presented by Mathieu Gaudin 

Wednesday, October 23 

• 9:30 AM | Validation of an LCMS Hybrid Assay with EVOSEP Cleanup for the Quantitation of Islet Amyloid Polypeptide in Human Plasma (#W0930-06-34) | Presented by Shane Karni
• 10:30 AM | Distribution of Standard-of-Care Antituberculosis Drugs in Cynomolgus Macaque Lungs (#W1030-02-08) | Presented by Mathieu Gaudin